LOADING
Comparing Procter & Gamble (PG) and Merck & Company (MRK) across the Consumer Staples and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | PG | MRK |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $336.6B | $356.0B |
| P/E Ratio | 21.9 | 116.4 |
| Forward P/E | 21.2 | 15.3 |
| PEG Ratio | 3.79 | 2.71 |
| EPS | $6.62 | $1.24 |
| Revenue Growth (YoY) | 1.5% | 5.1% |
| Profit Margin | 18.4% | 4.8% |
| Return on Equity | 30.3% | 7.0% |
| Dividend Yield | 2.96% | 2.31% |
| Beta | 0.38 | 0.23 |
| 52-Week High | $164.77 | $156.00 |
| 52-Week Low | $134.62 | $79.67 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. Procter & Gamble trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Procter & Gamble offers a higher dividend yield for income investors. Procter & Gamble has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.